Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.
(Q35941128)
scientific article
scientific article
Language:
Current Data About
Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.
other details
| description | scientific article |
External Links
| (P356) |
10.1111/J.1742-1241.2004.00318.X
|
| (P698) |
15529521
|